Вестник хирургии имени И.И. Грекова

Расширенный поиск


Полный текст:


Nowadays, according to data of WHO, the diabetes mellitus was diagnosed in more than 280 million people. The diabetes mellitus type II had 90% patients. The applied methods of conservative therapy seldom lead to euglycemia condition of patients. Last years the treatment of diabetes mellitus was carried out by the method of different bariatic interventions. Good results was obtained, they should be analyzed and investigate. The results of treatment of 142 patients from 628 patients (with type II) were estimated. The patients were undergone by different bariatic interventions. Modern laparoscopic operations were performed on all the patients. Controlled bandage of stomach had 81 of patients. Gastric resection was performed in 28. Gastric bypass surgery was carried out in 22 of patients and biliopancreatic diversion — in 11. The improvement of control of leukemia level was obtained. Diabetes type II could be treated by surgical methods. The best results were obtained after combined operations, which potentially could present an alternative method of treatment of type II diabetes.

Об авторах

Валерий Михайлович Седов
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Михаил Борисович Фишман
Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова

Список литературы

1. Консенсус Российских экспертов по проблеме метаболического синдромав Российской Федерации: определение, диагностические критерии, первичная профилактикаи лечение // Рациональная Фармакотерапияв кардиологии. 2010. Т. 6 (4). С. 599–606.

2. Седов В. М., Фишман М. Б. Лапароскопическая хирургия ожирения: Практическое руководство. Атлас. СПб., 2009.

3. Bittner R., Bittner B., Beger H. G. Homeostasis of glucose and gastric resection: the influence of the food passage through the duodenum // Z Gastroenterol. 1981. Vol. 19. P. 698–707.

4. Brolin R. E., LaMarca L. B., Kenler H. A. Malabsorptive gastric bypass in patients with superobesity // J. Gastrointest. Surg. 2002. Vol. 6. P. 195–205.

5. Buchwald H., Avidor Y., Braunwald E. Bariatric surgery:a systematic review and meta-analysis // JAMA. 2004. Vol. 292. P. 1724– 1737.

6. Cavaghan M. K., Ehrmann D. A., Polonsky K. S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance // J. Clin. Invest. 2000. Vol. 106. P. 529–333.

7. Cohen R. V., Schiavon C. A., Pinheiro J. S. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–54 kg/m2:a report of 2 cases // Surg. Obes. Relat. Dis. 2007. № 3. Vol. 2. P. l95–197.

8. Cummings D. E., Overduin J., Foster-Schuhert K. E. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution // J. Clin. Endocrinol. Metab. 2004. Vol. 89. P. 2315–2608.

9. Cummings D. E., Overduin J., Foster-Schubert K. E. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery // Surg. Obes. Relat. Dis. 2007. Vol. 2, № 3. P. 109–115.

10. Cummings D. E., Weigle D. S., Frayo R. S. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery // N. Engl. J. Med. 2002. Vol. 346. P. 1623–1630.

11. Cowan G. S., Buffington C. K. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery // Word J. Surg. 1998. Vol. 22. P. 987–992.

12. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M. Oxidative stress and stress activated signaling pathways:a unifying hypothesis of type 2 diabetes // Endocr. Rev. 2002. Vol. 23. P. 599–622.

13. Faraj M., Jones P., Sniderman A. D. Enhanced dietary fat clearance in postobese women // J. Lipid Res. 2001. Vol. 42. P. 571–580.

14. Foley E. F., Benotti P. N., Borlase B. C. Impact of gastric restrictive surgery on hypertension in the morbidly obese // Am J. Surg. 1992. Vol. 163. P. 294–297.

15. Friedman N. M., Sancetta A. J., Magovern G. J. The amelioration of diabetes mellitus following subtotal gastrectomy // Surg. Gynecol. Obstetr. 1955. Vol. 100. P. 201–204.

16. Holdstok C., Engstrom B. E., Ohrvall M. // J. Clin. Endocrinol. Metab. 2003. Vol. 88. P. 3177–3183.

17. Korner J., Bessler M., Cirilo L. J. Effects of Roux-en — Y gastric bypass surgery on fasting and pastprandial concentrations of plasma ghrelin, peptide YY, and insulin // J. Clin. Endocrinol. Metab. 2005. Vol. 90. P. 165–359.

18. Lewis G. F., Carpentier A., Adeli K., Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes // Endocr. Rev. 2002. Vol. 23. P. 201–229.

19. Le Roux C. W., Aylwin S. J., Baiterham R. L. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters // Ann Surg. 2006. Vol. 243. P. 108–114.

20. Lima J., Helena L., Oliveira S. Rapid resolution of diabetes after gastric bypass // Obes. Surg. 2005. Vol. 15. P. 448–449.

21. MacDonald K. G., Long S. D., Swanson M. S. The gastric bypass operation reduces the progression and mortality of non-insulindependent diabetes mellitus // J. Gastrointest. Surg. 1997. Vol. 1. P. 213–220.

22. MacLean L. D., Rhode B. M., Nohr C. W. Long-or short-limb gastric bypass? // J. Gastrointest. Surg. 2001. Vol. 5. P. 525–530.

23. Mahler R. J., Adler M. L. Clinical review 102: type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment // J. Clin. Endocrinol. Metab. 1999. Vol. 84. P. 1165–1171.

24. Mason E. E. The mechanism of surgical treatment of type 2 diabetes // Obes. Surg. 2005. Vol. 15. P. 459–461.

25. Mason E. E. Ileal transposition and enteroglucagim/GLP1 in obesity (and diabetic?) surgery // Obes. Surg. 1999. Vol. 9. P. 223–228.

26. Mingrone G., De Gaetano A., Greco A. V. Reversibility of insulin resistance in ohese diabetic patients: role of plasma lipids // Diabetologia. 1997. Vol. 40. P. 599–605.

27. Noya G., Cossu M.l., Coppola M. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type 2: results in the first 10 cases // Obes. Surg. 1998. Vol. 8. P. 67–72.

28. Patriti A., Facchiano E., Sanna A. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery // Obes. Surg. 2004. Vol. 14. P. 840–848.

29. Ponce J., Haynes B., Paynter S. Effect of lap-band-induced weight loss on type 2 diabetes mellitus and hypertension // Obes. Surg. 2004. Vol. 14. P. 1335–1342.

30. Pories W. J. Diabetes: the evolution of anew paradigm // Ann Surg. 2004. Vol. 39. P. 12–13.

31. Pories W. J., Albrccht R. J. Etiology of type II diabetes mellitus: role of the foregut // World J. Surg. 2001. Vol. 25. P. 527–531.

32. Pories W. J., MacDonald K. G., Morgan E. J. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up // Am J. Clin. Nutr. 1992. Vol. 55. (Suppl. 2). P. 582–585.

33. Pories W. J., Swanson M. S., MacDonald K. G. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus // Ann Surg. 1995. Vol. 222. P. 339–350.

34. Rubino F., Gagner M. Potential of surgery for curing type 2 diabetes mellitus // Ann Surg. 2002. Vol. 236. P. 554–559.

35. Rubino F., Gagner M., Gentileschi P. The early effect of the Roux-en-Y gastric, bypass on hormones involved in body weight regulation and glucose, metabolism // Ann Surg. 2004. Vol. 240. P. 236–242.

36. Rubino F., Forgione A., Cummings D. The mechanism of diabetes control after gastrointestinal bypass surgery revealsa role of the proximal small intestine in the pathophysiology of type 2 diabetes // Ann Surg. 2006. Vol. 244 (5). P. 74l–749.

37. Rubino F., Marescaux J. Effect of duodenal-jejunal exclusion ina non-obese animal model of type 2 diabetes:a new perspective, for an old disease // Ann Surg. 2004. Vol. 239. P. 1–11.

38. Schauer P. R., Burcuera B., Ikramuddin S. Effect of laparoscopic Roux-en Ygastric bypass on type 2 diabetes mellitus // Ann Surg. 2003. Vol. 238. P. 467–484.

39. Schauer P. R., Ikramuddin S., Gourash W. Outcomes after laparoscopic roux-en-Y gastric bypass for morbid obesity // Ann Surg. 2000. Vol. 232. P. 515–529.

40. Scopinaro N., Adami G. F., Marinari G. M. Biliopancreatic diversion // World J. Surg. 1998. Vol. 22. P. 936–946.

41. Scopinaro N., Marinari G. M., Camerini G. B. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome:a longterm follow-up study // Diabetes Care. 2005. Vol. 28. P. 2406–2411.

42. Sjostrom L., Lindroos A. K., Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery // N. Engl. J. Med. 2004. Vol. 351. P. 2683–2693.

43. Smith S., Enwards C. B., Goodman G. N. Changes in diabetic management after Roux en-Y gastric bypass // Obes. Surg. 1996. Vol. 6. P. 345–348.

44. World Diabetes Day. United Nations Resolution, General Assembly 61/225.18 Jan 2007.


Для цитирования:

Седов В.М., Фишман М.Б. МЕТАБОЛИЧЕСКАЯ ХИРУРГИЯ В ЛЕЧЕНИИ САХАРНОГО ДИАБЕТА 2-го ТИПА. Вестник хирургии имени И.И. Грекова. 2013;172(5):092-097.

For citation:

Sedov V.M., Fishman M.B. METABOLIC SURGERY IN TREATMENT OF DIABETES MELLITUS OF TYPE II. Grekov's Bulletin of Surgery. 2013;172(5):092-097. (In Russ.)

Просмотров: 261

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 0042-4625 (Print)
ISSN 2686-7370 (Online)